Facteur de croissance placentaire (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Facteur de croissance placentaire" in French language version.

refsWebsite

Global rank French rank

12doi.org

2^nd place

3^rd place

3nih.gov

4^th place

12^th place

3sciencedirect.com

149^th place

80^th place

2ensembl.org

1,626^th place

2,018^th place

2bloodjournal.org

low place

4,294^th place

1nejm.org

2,374^th place

298^th place

1plos.org

2,112^th place

666^th place

1ahajournals.org

3,608^th place

659^th place

1jbc.org

4,455^th place

1,915^th place

1nature.com

234^th place

147^th place

1jci.org

low place

3,702^nd place

1atsjournals.org

low place

4,703^rd place

ahajournals.org

circ.ahajournals.org

(en) Chappell LC, Duckworth S, Seed PT et al., « Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: A prospective multicenter study », Circulation, vol. 128, n^o 19,‎ 2013, p. 2121-2131 (DOI 10.1161/CIRCULATIONAHA.113.003215, lire en ligne).

atsjournals.org

(en) Tsao PN, Su YN, Li H et al., « Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema », Am J Respir Crit Care Med, vol. 169, n^o 4,‎ 2004, p. 505–511 (PMID 14644931, DOI 10.1164/rccm.200306-774OC, lire en ligne).

bloodjournal.org

(en) Perelman N, Selvaraj SK, Batra S et al., « Placenta growth factor activates monocytes and correlates with sickle cell disease severity », Blood, vol. 102, n^o 4,‎ 2003, p. 1506–1514 (DOI 10.1182/blood-2002-11-3422, lire en ligne).
(en) Patel N, Gonsalves CS, Yang M, Malik P et Kalra VK, « Placenta growth factor induces 5-lipoxygenase–activating protein to increase leukotriene formation in sickle cell disease », Blood, vol. 113, n^o 5,‎ 2009, p. 1129–1138 (DOI 10.1182/blood-2008-07-169821, lire en ligne).

doi.org

dx.doi.org

(en) Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR et Torry DS, « Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast », Placenta, vol. 18, n^o 8,‎ 1997, p. 657–665 (DOI 10.1016/S0143-4004(97)90007-2, lire en ligne).
(en) Knudsen UB, Kronborg CS, Von Dadelszen P, Kupfer K, Lee SW, Vittinghus E, Allen JG et Redman CW, « A single rapid point-of-care placental growth factor determination as an aid in the diagnosis of preeclampsia », Pregnancy Hypertens, vol. 2, n^o 1,‎ 2011, p. 8–15 (DOI 10.1016/j.preghy.2011.08.117, lire en ligne).
(en) Levine RJ, Maynard SE, Qian C et al., « Circulating angiogenic factors and the risk of preeclampsia », N Engl J Med, vol. 350, n^o 7,‎ 2004, p. 672–683 (DOI 10.1056/NEJMoa031884, lire en ligne).
(en) Robinson CJ, Johnson DD, Chang EY, Armstrong DM et Wang W, « Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia », Am J Obstet Gynecol, vol. 195, n^o 1,‎ 2006, p. 255–259 (DOI 10.1016/j.ajog.2005.12.049, lire en ligne).
(en) Sibiude J, Guibourdenche J, Dionne MD, Le Ray C, Anselem O, Serreau R, Goffinet F et Tsatsaris V, « Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction », PLoS ONE, vol. 7,‎ 2012, e50208 (DOI 10.1371/journal.pone.0050208, lire en ligne).
(en) Chappell LC, Duckworth S, Seed PT et al., « Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: A prospective multicenter study », Circulation, vol. 128, n^o 19,‎ 2013, p. 2121-2131 (DOI 10.1161/CIRCULATIONAHA.113.003215, lire en ligne).
(en) Perelman N, Selvaraj SK, Batra S et al., « Placenta growth factor activates monocytes and correlates with sickle cell disease severity », Blood, vol. 102, n^o 4,‎ 2003, p. 1506–1514 (DOI 10.1182/blood-2002-11-3422, lire en ligne).
(en) Patel N, Sundaram N, Yang M, Madigan C, Kalra VK et Malik P, « Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD) », J Biol Chem, vol. 285,‎ 2010, p. 16713–16722 (DOI 10.1074/jbc.M110.101691, lire en ligne).
(en) Hou HH, Cheng SL, Liu HT, Yang FZ, Wang HC et Yu CJ, « Elastase induced lung epithelial cell apoptosis and emphysema through placenta growth factor », Cell Death Dis, vol. 4,‎ 2013, article n^o e793 (DOI 10.1038/cddis.2013.329, lire en ligne).
(en) Patel N, Gonsalves CS, Yang M, Malik P et Kalra VK, « Placenta growth factor induces 5-lipoxygenase–activating protein to increase leukotriene formation in sickle cell disease », Blood, vol. 113, n^o 5,‎ 2009, p. 1129–1138 (DOI 10.1182/blood-2008-07-169821, lire en ligne).
(en) Eiymo Mwa Mpollo MS et al., « Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13 », J Clin Invest, vol. 126, n^o 2,‎ 2016, p. 571-584 (DOI 10.1172/JCI77250, lire en ligne).
(en) Tsao PN, Su YN, Li H et al., « Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema », Am J Respir Crit Care Med, vol. 169, n^o 4,‎ 2004, p. 505–511 (PMID 14644931, DOI 10.1164/rccm.200306-774OC, lire en ligne).

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000119630 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000004791 - Ensembl, May 2017

jbc.org

(en) Patel N, Sundaram N, Yang M, Madigan C, Kalra VK et Malik P, « Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD) », J Biol Chem, vol. 285,‎ 2010, p. 16713–16722 (DOI 10.1074/jbc.M110.101691, lire en ligne).

jci.org

(en) Eiymo Mwa Mpollo MS et al., « Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13 », J Clin Invest, vol. 126, n^o 2,‎ 2016, p. 571-584 (DOI 10.1172/JCI77250, lire en ligne).

nature.com

(en) Hou HH, Cheng SL, Liu HT, Yang FZ, Wang HC et Yu CJ, « Elastase induced lung epithelial cell apoptosis and emphysema through placenta growth factor », Cell Death Dis, vol. 4,‎ 2013, article n^o e793 (DOI 10.1038/cddis.2013.329, lire en ligne).

nejm.org

(en) Levine RJ, Maynard SE, Qian C et al., « Circulating angiogenic factors and the risk of preeclampsia », N Engl J Med, vol. 350, n^o 7,‎ 2004, p. 672–683 (DOI 10.1056/NEJMoa031884, lire en ligne).

nih.gov

ncbi.nlm.nih.gov

« Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
« Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine
(en) Tsao PN, Su YN, Li H et al., « Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema », Am J Respir Crit Care Med, vol. 169, n^o 4,‎ 2004, p. 505–511 (PMID 14644931, DOI 10.1164/rccm.200306-774OC, lire en ligne).

plos.org

journals.plos.org

(en) Sibiude J, Guibourdenche J, Dionne MD, Le Ray C, Anselem O, Serreau R, Goffinet F et Tsatsaris V, « Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction », PLoS ONE, vol. 7,‎ 2012, e50208 (DOI 10.1371/journal.pone.0050208, lire en ligne).

sciencedirect.com

(en) Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR et Torry DS, « Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast », Placenta, vol. 18, n^o 8,‎ 1997, p. 657–665 (DOI 10.1016/S0143-4004(97)90007-2, lire en ligne).
(en) Knudsen UB, Kronborg CS, Von Dadelszen P, Kupfer K, Lee SW, Vittinghus E, Allen JG et Redman CW, « A single rapid point-of-care placental growth factor determination as an aid in the diagnosis of preeclampsia », Pregnancy Hypertens, vol. 2, n^o 1,‎ 2011, p. 8–15 (DOI 10.1016/j.preghy.2011.08.117, lire en ligne).
(en) Robinson CJ, Johnson DD, Chang EY, Armstrong DM et Wang W, « Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia », Am J Obstet Gynecol, vol. 195, n^o 1,‎ 2006, p. 255–259 (DOI 10.1016/j.ajog.2005.12.049, lire en ligne).